SCHEMBL1122298

SCHEMBL1122298

O=C(O)CS(=O)(=O)Nc1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.52
CA1 P00915 2/20 0.52
CYP1A1 P04798 2/20 0.46
HPGD P15428 7/20 0.45
LMNA P02545 4/20 0.45
UQCRB P14927 2/20 0.45
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 2/20 0.42
TP53 P04637 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
RECQL P46063 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 4/20 0.41
GFER P55789 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
POLB P06746 2/20 0.41
MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL831034 0.84 HPGD (0.51) CA2CA1HPGDLMNAALDH1A1
SCHEMBL830095 0.83 CA1 (0.50) CA2CA1HPGDLMNAGAA
SCHEMBL6665659 0.83 CA1 (0.50) CA2CA1HPGDLMNAALOX15
SCHEMBL2557584 0.80 HPGD (0.65) CA2CA1HPGDLMNAALDH1A1
SCHEMBL1122574 0.80 CA1 (0.56) CA2CA1CA12CA4CA7
SCHEMBL15904304 0.79 HPGD (0.41) CA2CA1HPGDLMNAALDH1A1
SCHEMBL829810 0.79 CA1 (0.54) CA2CA1HPGDLMNAALDH1A1
SCHEMBL6295481 0.78 HPGD (0.64) CA2CA1HPGDLMNAUQCRB
SCHEMBL18047835 0.76 CA1 (0.55) CA2CA1CYP1A1HPGDLMNA
SCHEMBL11504884 0.74 KMT2A (0.56) CA2CA1HPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379508-B9 N-(ARYL)-2-ARYLETHENESULFONAMIDES AND THERAPEUTIC USES THEREOF UNIV TEMPLE (US) 2011-02-09 EP disclosed
EP-1379508-B1 N-(ARYL)-2-ARYLETHENESULFONAMIDES AND THERAPEUTIC USES THEREOF UNIV TEMPLE (US) 2010-09-01 EP disclosed